Steve Treon, MD, PhD, is a Professor at Harvard Medical School and the Director of the Bing Center for Waldenström’s macroglobulinemia (WM) at the Dana-Farber Cancer Institute in Boston, USA.
Aside from countless national and global lectures and 170 original reports, 28 book chapters and editorials, and more than 185 abstracts, Professor Treon has also been a guiding force in developing an awareness of this rare disease. He is the driving force behind the International Physician Symposiums on WM. He organized the first biennial ‘Summit’, a meeting of patients and physicians in Boston in 2001, which was followed by four Summits in the USA and Canada. Professor Treon has taken WM to a level where the understanding of the disease on a clinical, laboratory, and patient-advocacy scale has grown to a visitation of more than 2200 patients per year.